Search results for "Theranostic"

showing 10 items of 55 documents

Stimuli-Responsive Polymeric Nanocarriers for Drug Delivery, Imaging, and Theragnosis.

2020

In the past few decades, polymeric nanocarriers have been recognized as promising tools and have gained attention from researchers for their potential to efficiently deliver bioactive compounds, including drugs, proteins, genes, nucleic acids, etc., in pharmaceutical and biomedical applications. Remarkably, these polymeric nanocarriers could be further modified as stimuli-responsive systems based on the mechanism of triggered release, i.e., response to a specific stimulus, either endogenous (pH, enzymes, temperature, redox values, hypoxia, glucose levels) or exogenous (light, magnetism, ultrasound, electrical pulses) for the effective biodistribution and controlled release of drugs or genes…

LiposomeBiodistributionMaterials sciencePolymers and PlasticsBiocompatibilitytheranostictechnology industry and agricultureimagingNanotechnologyGeneral ChemistryReviewexogenous stimuliControlled releasestimuli-responsivelcsh:QD241-441Light intensitystimuli-responsive targetinglcsh:Organic chemistryDendrimerDrug deliverydrug deliveryNanomedicineendogenous stimuliPolymers
researchProduct

A top-down synthesis route to ultrasmall multifunctional Gd-based Silica nanoparticles for theranostic applications

2013

International audience; New, ultrasmall nanoparticles with sizes below 5 nm have been obtained. These small rigid platforms (SRP) are composed of a polysiloxane matrix with DOTAGA (1,4,7,10-tetraazacyclododecane-1-glutaric anhydride-4,7,10-triacetic acid)-Gd3+ chelates on their surface. They have been synthesised by an original top-down process: 1) formation of a gadolinium oxide Gd2O3 core, 2) encapsulation in a polysiloxane shell grafted with DOTAGA ligands, 3) dissolution of the gadolinium oxide core due to chelation of Gd3+ by DOTAGA ligands and 4) polysiloxane fragmentation. These nanoparticles have been fully characterised using photon correlation spectroscopy (PCS), transmission elec…

Magnetic Resonance SpectroscopySiloxanesGadoliniumtheranosticAnalytical chemistryContrast Mediachemistry.chemical_elementNanoparticle02 engineering and technologySubstance P010402 general chemistry01 natural sciencesCatalysisFluorescence spectroscopylaw.inventionHeterocyclic Compounds 1-RingMicroscopy Electron TransmissionDynamic light scatteringlawcancer[CHIM]Chemical SciencesChelationSpectroscopyElectron paramagnetic resonanceOrganic ChemistryGeneral ChemistryNuclear magnetic resonance spectroscopySilicon Dioxide021001 nanoscience & nanotechnologyMagnetic Resonance Imaging0104 chemical sciencesSpectrometry Fluorescencechemistrysilicananoparticlesgadolinium0210 nano-technologyRadiotherapy Image-GuidedNuclear chemistry
researchProduct

Heat shock protein 60 levels in tissue and circulating exosomes in human large bowel cancer before and after ablative surgery.

2015

BACKGROUND: Heat shock protein 60 (Hsp60) is a chaperonin involved in tumorigenesis, but its participation in tumor development and progression is not well understood and its value as a tumor biomarker has not been fully elucidated. In the current study, the authors presented evidence supporting the theory that Hsp60 has potential as a biomarker as well as a therapeutic target in patients with large bowel cancer. METHODS: The authors studied a population of 97 subjects, including patients and controls. Immunomorphology, Western blot analysis, and quantitative real-time polymerase chain reaction were performed on tissue specimens. Exosomes were isolated from blood and characterized by electr…

MaleCancer ResearchMacrophageBlotting WesternNatural killer cellEnzyme-Linked Immunosorbent AssayAdenocarcinomaExosomesReal-Time Polymerase Chain ReactionMitochondrial ProteinsHeat shock protein 60 (Hsp60)Biomarkers TumorHumansColon adenocarcinomaAgedColon adenocarcinoma; Exosomes; Heat shock protein 60 (Hsp60); Macrophages; Natural killer cells; Plasma cell membrane; Theranostics; Cancer Research; OncologyAged 80 and overPlasma cell membraneChaperonin 60Middle AgedImmunohistochemistryExosomeTheranosticOncologyColonic NeoplasmsFemaleCancer
researchProduct

Alpha emitting nuclides in nuclear medicine theranostics.

2021

Theranostic applications with radio-isotopes currently are rapidly progressing and expand nuclear medicine application in clinical routine. Alpha emitting isotopes, in particular, have long been hypothesized to achieve relevant advances for the treatment of malignancies. Here, an overview of their properties and the knowledge of radiobiology is reviewed in view of clinical translation. Clinical evidence of radiopharmaceuticals based on alpha emitters is summarized with a focus on recent developments for treatment of metastasized castration resistant prostate cancer.Theranostische Anwendungen mit Radioisotopen machen derzeit rasche Fortschritte und erweitern den Einsatz der Nuklearmedizin in…

MaleRadiobiologybusiness.industryProstatic NeoplasmsGeneral MedicineCastration resistantClinical routineTheranostic NanomedicineClinical evidenceMedicineHumansRadiology Nuclear Medicine and imagingNuclideNuclear MedicinePrecision MedicineRadiopharmaceuticalsNuclear medicinebusinessRadionuclide ImagingNuklearmedizin. Nuclear medicine
researchProduct

Naphthalimide imidazolium-based supramolecular hydrogels as bioimaging and theranostic soft materials

2020

1,8-Naphthalimide-based imidazolium salts differing for the alkyl chain length and the nature of the anion were synthesized and characterized to obtain fluorescent probes for bioimaging applications. First, their self-assembly behavior and gelling ability were investigated in water and water/dimethyl sulfoxide binary mixtures. Only salts having longer alkyl chains were able to give supramolecular hydrogels, whose properties were investigated by using a combined approach of fluorescence, resonance light scattering, and rheology measurements. Morphological information was obtained by scanning electron microscopy. In addition, conductive properties of organic salts in solution and gel state we…

Materials scienceCell SurvivalMacromolecular SubstancesSurface PropertiesScanning electron microscopeimidazolium salts010402 general chemistry01 natural sciencesTheranostic Nanomedicinechemistry.chemical_compoundbioimaging; fluorescence; imidazolium salts; naphthalimide; supramolecular hydrogelsCell Line TumorPhase (matter)HumansGeneral Materials ScienceParticle SizeSettore BIO/06 - Anatomia Comparata E CitologiabioimagingAlkylFluorescent Dyeschemistry.chemical_classificationMolecular Structure010405 organic chemistryDimethyl sulfoxideOptical ImagingImidazolesHydrogelsBiological activitySettore CHIM/06 - Chimica OrganicaResonance (chemistry)Combinatorial chemistryFluorescencenaphthalimide0104 chemical sciencesNaphthalimideschemistrySelf-healing hydrogelssupramolecular hydrogelsfluorescence
researchProduct

Versatile preparation of silica nanocapsules for biomedical applications

2020

Core–shell nanocapsules are receiving increasing interest for drug delivery applications. Silica nanocapsules have been the focus of intensive studies due to their biocompatibility, versatile silica chemistry, and tunable porosity. However, a versatile one-step preparation of silica nanocapsules with well-defined core–shell structure, tunable size, flexible interior loading, and tailored shell composition, permeability, and surface functionalization for site-specific drug release and therapeutic tracking remains a challenge. Herein, an interfacially confined sol–gel process in miniemulsion for the one-step versatile preparation of functional silica nanocapsules is developed. Uniform nanocap…

Materials scienceDRUG DELIVERYCORE–SHELL NANOCAPSULESNanotechnologyGeneral ChemistryCondensed Matter PhysicsControlled releaseNanocapsules//purl.org/becyt/ford/1 [https]CONTROLLED RELEASE//purl.org/becyt/ford/2 [https]//purl.org/becyt/ford/2.10 [https]Drug deliverySILICA NANOCARRIERSTHERANOSTIC NANOPLATFORMS//purl.org/becyt/ford/1.4 [https]General Materials Science
researchProduct

Terbium Medical Radioisotope Production: Laser Resonance Ionization Scheme Development

2021

Terbium (Tb) is a promising element for the theranostic approach in nuclear medicine. The new CERN-MEDICIS facility aims for production of its medical radioisotopes to support related R&D projects in biomedicine. The use of laser resonance ionization is essential to provide radioisotopic yields of highest quantity and quality, specifically regarding purity. This paper presents the results of preparation and characterization of a suitable two-step laser resonance ionization process for Tb. By resonance excitation via an auto-ionizing level, the high ionization efficiency of 53% was achieved. To simulate realistic production conditions for Tb radioisotopes, the influence of a surplus of Gd at…

Medicine (General)theranosticsMaterials scienceCERN-MEDICISIon beam530 PhysicsGadolinium610 Medizinchemistry.chemical_elementTerbiumTERBIUMSURFACE PROPERTYIsotope separationlaw.inventionGADOLINIUMR5-920COMPARATIVE STUDYlawIonization610 Medical sciencesLASER RESONANCE IONIZATIONSAPPHIRE LASER [TI]ARTICLERADIOCHEMISTRYisotope separationTANTALUMOriginal ResearchTHERANOSTICSTi:Sapphire laserRISIKO MASS SEPARATORterbiumATOMIC SPECTROMETRYRadiochemistryTi:sapphire laserGeneral Medicine530 PhysikCharacterization (materials science)CONTROLLED STUDYchemistryRISIKO mass separatorION CURRENTMedicineISOTOPE SEPARATIONIONIZATIONAtomic ratiolaser resonance ionizationgadolinium
researchProduct

Extracellular Vesicle-Mediated Cell–Cell Communication in the Nervous System: Focus on Neurological Diseases

2019

Extracellular vesicles (EVs), including exosomes, are membranous particles released by cells into the extracellular space. They are involved in cell differentiation, tissue homeostasis, and organ remodelling in virtually all tissues, including the central nervous system (CNS). They are secreted by a range of cell types and via blood reaching other cells whose functioning they can modify because they transport and deliver active molecules, such as proteins of various types and functions, lipids, DNA, and miRNAs. Since they are relatively easy to isolate, exosomes can be characterized, and their composition elucidated and manipulated by bioengineering techniques. Consequently, exosomes appear…

Nervous systemReviewCell CommunicationTheranostic NanomedicineCatalysilcsh:Chemistry0302 clinical medicineCell–cell interactionlcsh:QH301-705.5Tissue homeostasisSpectroscopyDrug Carriers0303 health sciencesnervous systemCell DifferentiationNeurodegenerative DiseasesComputer Science Applications1707 Computer Vision and Pattern RecognitionGeneral MedicineExtracellular vesicleComputer Science ApplicationsCell biologymedicine.anatomical_structureTheranostics toolExtracellular vesicleextracellular vesiclesneurological diseasesCell signalingCell typecell–cell interactionexosomesBiologyCatalysisInorganic Chemistry03 medical and health sciencesExtracellularmedicineCell-cell interactionHumansPhysical and Theoretical ChemistryMolecular Biology030304 developmental biologytheranostics toolsOrganic ChemistrybiomarkersBiomarkercentral nervous systemMicrovesiclesExosomelcsh:Biology (General)lcsh:QD1-999030217 neurology & neurosurgeryNeurological diseaseInternational Journal of Molecular Sciences
researchProduct

Clinical Translation and First In-Human Use of [44Sc]Sc-PSMA-617 for PET Imaging of Metastasized Castrate-Resistant Prostate Cancer

2017

Background: Various trivalent radiometals are well suited for labeling of DOTA-conjugated variants of Glu-ureido-based prostate-specific membrane antigen (PSMA) inhibitors. The DOTA-conjugate PSMA-617 has proven high potential in PSMA radioligand therapy (PSMA-RLT) of prostate cancer as well as PET imaging when labeled with lutetium-177 and gallium-68 respectively. Considering the relatively short physical half-life of gallium-68 this positron emitter precludes prolonged acquisition periods, as required for pre-therapeutic dosimetry or intraoperative applications. In this context, the positron emitter scandium-44 is an attractive alternative for PET imaging. We report the synthesis of [44Sc…

OncologyMalemedicine.medical_specialtytheranostics.Medicine (miscellaneous)Context (language use)SpleenGallium RadioisotopesLutetiumurologic and male genital diseases030218 nuclear medicine & medical imaging03 medical and health sciencesProstate cancerHeterocyclic Compounds 1-Ring0302 clinical medicineInternal medicinePositron Emission Tomography Computed TomographyLNCaPmedicineDosimetryHumansRadiometryPharmacology Toxicology and Pharmaceutics (miscellaneous)AgedRadioisotopesUrinary bladderChemistrybusiness.industryDipeptidesProstate-Specific Antigenmedicine.diseaseprostate cancerPSMA-617scandium-44Small intestineProstatic Neoplasms Castration-Resistantmedicine.anatomical_structurePET030220 oncology & carcinogenesisAbsorbed doseRadiopharmaceuticalsNuclear medicinebusinessScandiumResearch PaperHalf-LifeTheranostics
researchProduct

Copper radiopharmaceuticals for theranostic applications

2018

The growing advancement in nuclear medicine challenges researchers from several different fields to integrate imaging and therapeutic modalities in a theranostic radiopharmaceutical, which can be defined as a molecular entity with readily replaceable radioisotope to provide easy switch between diagnostic and therapeutic applications for efficient and patient-friendly treatment of diseases. For such a reason, the diagnostic and therapeutic potential of all five medical radionuclides of copper have thoroughly been investigated as they boost the hope for development of successful radiotheranostics. To facilitate the mutual understanding between all different specialists working on this multidi…

PharmacologyDose-Response Relationship DrugMolecular StructureChemistryOrganic ChemistryPersonalized treatmentNanotechnology02 engineering and technologyGeneral Medicine010402 general chemistry021001 nanoscience & nanotechnologyBiocompatible material01 natural sciencesTheranostic NanomedicineTherapeutic modalities0104 chemical sciencesStructure-Activity RelationshipCopper RadioisotopesDrug DiscoveryAnimalsHumansRadiopharmaceuticals0210 nano-technologyMolecular entityEuropean Journal of Medicinal Chemistry
researchProduct